Skip to main content
Clinical Trials/ACTRN12621001062819
ACTRN12621001062819
Completed
未知

Transcriptomic and proteomic changes associated with high intensity interval training-induced mitochondrial biogenesis within healthy adult human skeletal muscle

Victoria University0 sites40 target enrollmentAugust 12, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Victoria University
Enrollment
40
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 12, 2021
End Date
December 2, 2022
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Aged 18\-40 years old, Men \& Women
  • \- Be generally ‘healthy’: Non\-smoker, free from pre\-existing medical conditions (e.g., heart rhythm disturbance, elevated blood pressure, diabetes), cardiovascular abnormalities, respiratory conditions and musculoskeletal injuries.
  • \- Not taking prescription medication (e.g., beta\-blockers, anti\-arrhythmic drugs, statins or insulin sensitising drugs).
  • \- Undertaken less than the current weekly physical activity guidelines for adults (150 minutes of moderate intensity physical activity, or 75 minutes of vigorous intensity physical activity) for at least 3 months prior to the study.
  • \- Have a body mass index (BMI) between 18\.5\-34\.9 kg/m2

Exclusion Criteria

  • \- Current muscle or ligament injury of the lower body.
  • \- Current or previous cardiovascular or respiratory condition or abnormality.
  • \- Current metabolic disease (e.g. diabetes)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Changes at the level of the endometrium caused by Lipiodol intrauterine flush.Female subfertilityMedDRA version: 20.0 Level: LLT Classification code 10042392 Term: Subfertility (female) System Organ Class: 100000004872Therapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
EUCTR2017-004429-34-BEZ Brussel20
Completed
Not Applicable
Changes in metabolome and epigenome after drastic weight loss and identification of novel forms of monogenetic obesityExtreme ObesityGenetic dispositionE66Obesity
DRKS00011537niversitätsklinikum Ulm für Kinder- und JugendmedizinSektion Pädiatrische Endokrinologie u. Diabetologie, Interdisziplinäre Adipositasambulanz107
Active, not recruiting
Phase 1
Gene and protein expression after treatment of actinic keratosisActinic keratosesMedDRA version: 20.0Level: PTClassification code 10000614Term: Actinic keratosisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
EUCTR2021-005996-37-DKZealand University Hospital60
Recruiting
Not Applicable
Clinical Trial Protocol for Investigating Biological Characteristics of Different Syndromes in Heart Failure with Preserved Ejection Fraction (HFpEF) Based on Proteomics and Metabolomics StudiesHearth failure
ITMCTR2024000120Xi Yuan Hospital, China Academy of Chinese Medical Sciences
Recruiting
Not Applicable
Molecular and functional analysis of patients with defects of granulocytesD71Functional disorders of polymorphonuclear neutrophils
DRKS00030379Institut für Transfusionsmedizin150